• In late April 2026, Align Technology previewed several new digital orthodontic workflow tools and Invisalign innovations at the AAO 2026 Annual Session in Orlando, alongside reaffirmed 2026 guidance and first-quarter results showing higher sales, net income, and earnings per share versus a year earlier.
• An interesting angle for investors is how Align is using 3D printing and fully digital planning, such as the Invisalign Specifix Attachment System and enhanced palatal expander, to shift traditionally manual, chairside procedures into its integrated Align Digital Platform.
• We’ll now examine how Align’s push into fully digital, 3D‑printed chairside solutions could influence the company’s existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 39 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Align Technology Investment Narrative Recap

To own Align, you generally need to believe that digital orthodontics and integrated workflows across scanners, software, and aligners can support steady growth despite demand and pricing headwinds. The April AAO 2026 product preview and Q1 results, alongside reaffirmed 2026 guidance, modestly support that view, but they do not remove near term pressure from softer orthodontic case starts and pricing competition, which still look like the most important catalyst and risk right now.

The AAO 2026 preview of fully digital, 3D printed tools such as the Invisalign Specifix Attachment System and enhanced palatal expander is especially relevant here. These offerings tie directly into Align’s effort to shift manual, chairside work into its digital platform, which could matter for utilization of iTero scanners and ClinCheck and, over time, help counter concerns about mix shift to lower priced products and competitive discounting.

Yet investors also need to weigh how rising competition and pressure to discount clear aligners could affect Align’s ability to maintain margins and pricing power over time...

Align Technology's narrative projects $4.7 billion revenue and $726.5 million earnings by 2029. This requires 4.9% yearly revenue growth and about a $316 million earnings increase from $410.4 million today.

Uncover how Align Technology's forecasts yield a $201.69 fair value, a 25% upside to its current price.

Exploring Other Perspectives

While the AAO 2026 innovations highlight Align’s push into digital workflows, the most pessimistic analysts still see only about 3.4% annual revenue growth and earnings reaching roughly US$670.7 million by 2029, underscoring how differently you might view Align’s potential depending on how much weight you give to risks like intensifying price competition and commoditization in clear aligners.

Explore 6 other fair value estimates on Align Technology - why the stock might be worth as much as 71% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Align Technology research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Align Technology research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Align Technology's overall financial health at a glance.

Seeking Other Investments?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Uncover the next big thing with 27 elite penny stocks that balance risk and reward.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.